Tag: Survival rates
Pfizer Braftovi: Colorectal Cancer Survival Extended
Pfizer's Braftovi: Extending Survival in Colorectal CancerPfizer has recently announced a groundbreaking development in the world of oncology with their targeted cancer drug, Braftovi,...
New Hope for Endometrial Cancer Patients with FDA-Approved Immunotherapy
The U.S. Food and Drug Administration (FDA) recently approved a new drug for certain adult patients with endometrial cancer. The drug, called Jemperli (dostarlimab-gxly),...
BREAKING NEWS
Mass General Brigham vs. Dana-Farber: Hospital Battle Unveiled
A battle is brewing behind the scenes in the world of healthcare, as the future of cancer care hangs in the balance. The clash...
